Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $68.2800 (-6.11%) ($67.2700 - $72.4300) on Wed. Apr. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.86% (three month average) | RSI | 45 | Latest Price | $68.2800(-6.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) XBI(52%) IWC(49%) IWM(49%) | Factors Impacting LGND price | LGND will decline at least -2.93% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-16%) TLT(-4%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.93% (StdDev 5.86%) | Hourly BBV | 0 () | Intraday Trend | -3.1% | | | |
|
1 - 5 Day Possible Target | $43.22(-36.7%) | Resistance Level | $79.36 | 5 Day Moving Average | $70.38(-2.98%) | 10 Day Moving Average | $71.9(-5.03%) | 20 Day Moving Average | $79.36(-13.96%) | To recent high | -36.7% | To recent low | 7.7% | Market Cap | $1.097b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |